[go: up one dir, main page]

NZ335633A - Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases - Google Patents

Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases

Info

Publication number
NZ335633A
NZ335633A NZ335633A NZ33563397A NZ335633A NZ 335633 A NZ335633 A NZ 335633A NZ 335633 A NZ335633 A NZ 335633A NZ 33563397 A NZ33563397 A NZ 33563397A NZ 335633 A NZ335633 A NZ 335633A
Authority
NZ
New Zealand
Prior art keywords
pylori
polypeptides
recombinant
diagnosis
treatment
Prior art date
Application number
NZ335633A
Inventor
Douglas Smith
Richard A Alm
Peter C Doig
Zita Kabok
Lillian Marie Castriotta
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NZ335633A publication Critical patent/NZ335633A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Recombinant or substantially pure preparations of H. pylori polypeptides are described. The nucleic acids encoding the polypeptides also are described. The H. pylori polypeptides are useful for diagnostics and vaccine compositions, wherein the figure depicts an amino acid sequence alignment of five H. pylori proteins.
NZ335633A 1996-12-05 1997-12-05 Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases NZ335633A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75962596A 1996-12-05 1996-12-05
US82374597A 1997-03-25 1997-03-25
US89192897A 1997-07-14 1997-07-14
PCT/US1997/022104 WO1998024475A1 (en) 1996-12-05 1997-12-05 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof

Publications (1)

Publication Number Publication Date
NZ335633A true NZ335633A (en) 2000-10-27

Family

ID=27419527

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ335633A NZ335633A (en) 1996-12-05 1997-12-05 Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases

Country Status (18)

Country Link
EP (1) EP0964699A4 (en)
JP (1) JP2001510992A (en)
KR (1) KR20000069297A (en)
CN (1) CN1246799A (en)
AR (1) AR010337A1 (en)
AU (1) AU739641B2 (en)
BR (1) BR9714133A (en)
CA (1) CA2273199A1 (en)
EE (1) EE9900226A (en)
ID (1) ID21946A (en)
IL (1) IL129746A0 (en)
IS (1) IS5047A (en)
NO (1) NO992158L (en)
NZ (1) NZ335633A (en)
PL (1) PL333943A1 (en)
SK (1) SK57999A3 (en)
TR (1) TR199901262T2 (en)
WO (1) WO1998024475A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1124949B1 (en) * 1998-10-26 2006-07-12 Novozymes A/S Constructing and screening a dna library of interest in filamentous fungal cells
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AUPQ347199A0 (en) * 1999-10-15 1999-11-11 Csl Limited Novel polypeptide fragments
US6951729B1 (en) 1999-10-27 2005-10-04 Affinium Pharmaceuticals, Inc. High throughput screening method for biological agents affecting fatty acid biosynthesis
EP1330515A4 (en) * 2000-10-06 2005-12-07 Affinium Pharm Inc Methods of agonizing and antagonizing fabk
US7048926B2 (en) 2000-10-06 2006-05-23 Affinium Pharmaceuticals, Inc. Methods of agonizing and antagonizing FabK
WO2002066502A1 (en) * 2001-02-21 2002-08-29 Boren Thomas Helicobacter pylori sialic acid binding adhesin, saba and saba - gene
CN102176907A (en) * 2008-10-08 2011-09-07 免疫解决方案有限公司 Oral vaccines for producing mucosal immunity
CA3007036A1 (en) 2015-12-14 2017-06-22 Technische Universitat Munchen Helicobacter pylori vaccines
CN110343697B (en) * 2019-08-05 2024-07-12 南京昊斯亭网络科技有限公司 A method for extracting total DNA of plant pathogenic bacteria
CN113435168B (en) * 2021-06-10 2024-03-22 上海美吉生物医药科技有限公司 Automatic editing method, system, terminal and medium for glue pattern
CN114057854B (en) * 2021-09-30 2022-07-15 河北医科大学第四医院 Helicobacter pylori CD4+T cell tolerance polypeptide fusion antigen and application thereof
CN116162140B (en) * 2022-07-19 2025-09-09 四川大学华西医院 Helicobacter pylori recombinant antigen protein SecG, and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300139L (en) * 1993-01-19 1994-07-20 Medicarb Ab Preparation of a new drug

Also Published As

Publication number Publication date
NO992158L (en) 1999-07-05
BR9714133A (en) 2000-02-29
CN1246799A (en) 2000-03-08
EP0964699A1 (en) 1999-12-22
IL129746A0 (en) 2000-02-29
EP0964699A4 (en) 2005-04-06
KR20000069297A (en) 2000-11-25
AR010337A1 (en) 2000-06-07
WO1998024475A1 (en) 1998-06-11
PL333943A1 (en) 2000-01-31
TR199901262T2 (en) 1999-08-23
NO992158D0 (en) 1999-05-04
AU739641B2 (en) 2001-10-18
SK57999A3 (en) 2000-05-16
IS5047A (en) 1999-05-10
EE9900226A (en) 1999-12-15
CA2273199A1 (en) 1998-06-11
AU5895498A (en) 1998-06-29
ID21946A (en) 1999-08-12
JP2001510992A (en) 2001-08-07

Similar Documents

Publication Publication Date Title
GB2181138B (en) Recombinant alveolar surfactant protein
WO2000034317A3 (en) Method for reducing immunogenicity of proteins
ATE173478T1 (en) VARIANTS OF THE BOvine PANCREATIC TRYPSIN INHIBITOR, THEIR PREPARATION AND USE
EP2258383A3 (en) Antigenic peptides derived from telomerase
WO1995018830A3 (en) Inhibitors of human plasmin derived from the kunitz domains
AU1986588A (en) Growth hormone receptor
ZA943465B (en) Transforming growth factor alpha H1
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
WO2002008277A3 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
CA2175332A1 (en) Haemophilus transferrin receptor genes
IL82364A0 (en) Recombinant alveolar surfactant protein,its production and purification and pharmaceutical compositions containing it
NZ332565A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
IL80562A0 (en) Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it
NO991995L (en) Nucleic acid and amino acid sequences related to Heliobacter pylori and vaccine compositions thereof
AU5776799A (en) Modified hcv peptide vaccines
WO2000029434A3 (en) PNEUMOCOCCAL CHOLINE BINDING PROTEINS, CbpG AND CbpD, DIAGNOSTIC AND THERAPEUTIC USES THEREOF
AU1239997A (en) Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes
DK595187A (en) MINACTIVIN AND METHOD OF PRODUCING THEREOF
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
EP0780472A3 (en) Stress proteins
WO1990012807A3 (en) Purified, highly specific antibodies against gene products including retinoblastoma and method
EP0832972A3 (en) Cloning, expression and production of tasty peptides
MX9709846A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics.
CA2067334A1 (en) Recombinant production of lactoperoxidase
WO1998044094A3 (en) Helicobacter aliphatic amidase polypeptides, dna sequences encoding those polypeptides and uses thereof

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)